OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Massively parallel assessment of human variants with base editor screens
Ruth E. Hanna, Mudra Hegde, Christian Fagre, et al.
Cell (2021) Vol. 184, Iss. 4, pp. 1064-1080.e20
Open Access | Times Cited: 236
Ruth E. Hanna, Mudra Hegde, Christian Fagre, et al.
Cell (2021) Vol. 184, Iss. 4, pp. 1064-1080.e20
Open Access | Times Cited: 236
Showing 1-25 of 236 citing articles:
CRISPR technology: A decade of genome editing is only the beginning
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 519
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 519
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 334
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 334
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 327
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 327
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 275
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 275
Prime editing for precise and highly versatile genome manipulation
Peter J. Chen, David R. Liu
Nature Reviews Genetics (2022) Vol. 24, Iss. 3, pp. 161-177
Closed Access | Times Cited: 268
Peter J. Chen, David R. Liu
Nature Reviews Genetics (2022) Vol. 24, Iss. 3, pp. 161-177
Closed Access | Times Cited: 268
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Ruilin Tian, Anthony Abarientos, Jason Hong, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 7, pp. 1020-1034
Open Access | Times Cited: 254
Ruilin Tian, Anthony Abarientos, Jason Hong, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 7, pp. 1020-1034
Open Access | Times Cited: 254
The CRISPR-Cas toolbox and gene editing technologies
Guanwen Liu, Qiupeng Lin, Shuai Jin, et al.
Molecular Cell (2021) Vol. 82, Iss. 2, pp. 333-347
Open Access | Times Cited: 239
Guanwen Liu, Qiupeng Lin, Shuai Jin, et al.
Molecular Cell (2021) Vol. 82, Iss. 2, pp. 333-347
Open Access | Times Cited: 239
Functional interrogation of DNA damage response variants with base editing screens
Raquel Cuella-Martin, Samuel B. Hayward, Xiao Fan, et al.
Cell (2021) Vol. 184, Iss. 4, pp. 1081-1097.e19
Open Access | Times Cited: 194
Raquel Cuella-Martin, Samuel B. Hayward, Xiao Fan, et al.
Cell (2021) Vol. 184, Iss. 4, pp. 1081-1097.e19
Open Access | Times Cited: 194
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 192
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 192
A new era in functional genomics screens
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 159
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 159
CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 140
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 140
Saturation variant interpretation using CRISPR prime editing
Steven Erwood, Teija M.I. Bily, Jason Lequyer, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 885-895
Open Access | Times Cited: 130
Steven Erwood, Teija M.I. Bily, Jason Lequyer, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 885-895
Open Access | Times Cited: 130
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity
Monica E. Neugebauer, Alvin Hsu, Mandana Arbab, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 5, pp. 673-685
Open Access | Times Cited: 121
Monica E. Neugebauer, Alvin Hsu, Mandana Arbab, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 5, pp. 673-685
Open Access | Times Cited: 121
Predicting and interpreting large-scale mutagenesis data using analyses of protein stability and conservation
Magnus Haraldson Høie, Matteo Cagiada, Anders Haagen Beck Frederiksen, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110207-110207
Open Access | Times Cited: 99
Magnus Haraldson Høie, Matteo Cagiada, Anders Haagen Beck Frederiksen, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110207-110207
Open Access | Times Cited: 99
MEN1 mutations mediate clinical resistance to menin inhibition
Florian Perner, Eytan M. Stein, Daniela V. Wenge, et al.
Nature (2023) Vol. 615, Iss. 7954, pp. 913-919
Open Access | Times Cited: 96
Florian Perner, Eytan M. Stein, Daniela V. Wenge, et al.
Nature (2023) Vol. 615, Iss. 7954, pp. 913-919
Open Access | Times Cited: 96
Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens
John Morris, Christina M. Caragine, Zharko Daniloski, et al.
Science (2023) Vol. 380, Iss. 6646
Open Access | Times Cited: 94
John Morris, Christina M. Caragine, Zharko Daniloski, et al.
Science (2023) Vol. 380, Iss. 6646
Open Access | Times Cited: 94
Past, present, and future of CRISPR genome editing technologies
Martin Pacesa, Oana Pelea, Martin Jínek
Cell (2024) Vol. 187, Iss. 5, pp. 1076-1100
Open Access | Times Cited: 85
Martin Pacesa, Oana Pelea, Martin Jínek
Cell (2024) Vol. 187, Iss. 5, pp. 1076-1100
Open Access | Times Cited: 85
Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants
Francisco J. Sánchez‐Rivera, Bianca J. Diaz, Edward R. Kastenhuber, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 862-873
Open Access | Times Cited: 82
Francisco J. Sánchez‐Rivera, Bianca J. Diaz, Edward R. Kastenhuber, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 862-873
Open Access | Times Cited: 82
Massively parallel base editing to map variant effects in human hematopoiesis
Jorge D. Martin-Rufino, Nicole Castano, Michael Pang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2456-2474.e24
Open Access | Times Cited: 68
Jorge D. Martin-Rufino, Nicole Castano, Michael Pang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2456-2474.e24
Open Access | Times Cited: 68
CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 50
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 50
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Samah W. Awwad, Almudena Serrano-Benítez, John C. Thomas, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 477-494
Closed Access | Times Cited: 44
Samah W. Awwad, Almudena Serrano-Benítez, John C. Thomas, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 477-494
Closed Access | Times Cited: 44
Base editing screens map mutations affecting interferon-γ signaling in cancer
Matthew A. Coelho, Sarah Cooper, Magdalena E. Strauß, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 288-303.e6
Open Access | Times Cited: 42
Matthew A. Coelho, Sarah Cooper, Magdalena E. Strauß, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 288-303.e6
Open Access | Times Cited: 42
CRISPR engineering in organoids for gene repair and disease modelling
Maarten H. Geurts, Hans Clevers
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 32-45
Open Access | Times Cited: 40
Maarten H. Geurts, Hans Clevers
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 32-45
Open Access | Times Cited: 40
Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types
Samuel S. Kim, Buu Truong, Karthik A. Jagadeesh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Samuel S. Kim, Buu Truong, Karthik A. Jagadeesh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13